1. Potential Role of MicroRNA-375 as Biomarker in Human Cancers Detection: A Meta-Analysis.
- Author
-
Yan, Jin, She, Qiang, Shen, Xiaoran, Zhang, Yifeng, Liu, Bingtuan, and Zhang, Guoxin
- Subjects
- *
TUMOR classification , *TUMOR diagnosis , *CANCER patients , *CONFIDENCE intervals , *MEDICAL information storage & retrieval systems , *MEDLINE , *META-analysis , *ONLINE information services , *RACE , *TUMOR markers , *SYSTEMATIC reviews , *RECEIVER operating characteristic curves , *DESCRIPTIVE statistics , *EARLY detection of cancer , *ODDS ratio - Abstract
The association between circulating microRNA-375 (miR-375) expression and cancers has been studied; however, the results are inconsistent. We searched PubMed, Embase, and Web of Science for studies concerning the diagnostic value of miR-375 for cancer. The bivariate meta-analysis model was employed to summarize sensitivity, specificity, and diagnostic odds ratio (DOR) for miR-375 in the diagnosis of cancer. Summary receiver operating characteristic (SROC) curve analysis and the area under the curve (AUC) were also used to check the overall test performance. A total of 645 cancer patients and 421 cancer-free individuals from 12 studies were contained in this meta-analysis. The summary estimates revealed that the pooled sensitivity was 78% (95% confidence interval (CI): 64%–87%), the specificity was 74% (95% CI: 62%–84%), the DOR was 10.04 (95% CI: 6.01–16.77), and the AUC was 0.82 (95% CI: 0.79–0.85). In addition, we found that the diagnostic effect of miR-375 varies according to the race and cancer type. Our data suggest that miR-375 profiling has a potential to be used as a screening test for cancers but the specific race and cancer should be considered. More studies on the diagnostic value of miR-375 for cancer are needed in the future. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF